Acquisitions20 Aug 2025, 06:41 pm
Glenmark Pharmaceuticals Acquires Remaining Stake in O2 Renewable Energy XXIV Private Limited
AI Summary
Glenmark Pharmaceuticals Ltd has completed its acquisition of a 32.95% stake in O2 Renewable Energy XXIV Private Limited. This follows an initial investment of Rs. 1.75 Crores made in December 2024, with the remaining Rs. 0.24 Crores invested recently. The company had previously disclosed the necessary information regarding this acquisition in accordance with SEBI regulations.
Key Highlights
- Glenmark Pharmaceuticals has acquired a 32.95% stake in O2 Renewable Energy XXIV Private Limited
- The company has invested a total of Rs. 1.99 Crores in the acquisition
- This follows an initial investment of Rs. 1.75 Crores made in December 2024
- The remaining Rs. 0.24 Crores have been invested recently
- The acquisition has been made in compliance with SEBI regulations